Functional characterization of T3SS C-ring component VscQ and evaluation of its mutant as a live attenuated vaccine in zebrafish (Danio rerio) model

Publication date: Available online 27 May 2020Source: Fish &Shellfish ImmunologyAuthor(s): Peiwen Wu, Shihui Zhou, Zehui Su, Chang Liu, Fuyuan Zeng, Huanying Pang, Miao Xie, Jichang Jian
Source: Fish and Shellfish Immunology - Category: Biology Source Type: research

Related Links:

Publication date: Available online 13 July 2020Source: Veterinary MicrobiologyAuthor(s): Eda Baldan Toker, Gizem Aytogu, Berfin Kadiroglu, OzerAtes, Kadir Yesilbag
Source: Veterinary Microbiology - Category: Veterinary Research Source Type: research
Immune responses triggered in 45 participants in phase one trial, without safety issues
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
Saying it plans to launch what will likely be one of the largest clinical trials the drug industry has seen before in less than two weeks, Moderna Inc. revealed more evidence from an early-stage trial of its potential vaccine that indicated it could be successful.   Moderna (Nasdaq: MRNA) released the data from the first test of its Covid-19 vaccine after markets closed Tuesday, which included 42 of the 45 subjects originally enrolled in the NIH-led study (An additional 110 subjects were enrolled…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
Some experts say a vaccine puffed in the nose would be better at protecting people from infection. But nasal vaccines won ’t be ready right away.
Source: NYT Health - Category: Consumer Health News Authors: Tags: your-feed-science Coronavirus (2019-nCoV) Vaccination and Immunization Immune System Source Type: news
Exactly how Americans will greet a COVID-19 vaccine is unknown, but polls have suggested many will be wary.
Source: WebMD Health - Category: Consumer Health News Source Type: news
NIH-sponsored Phase 1 trial tested mRNA vaccine.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news
Here is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
Condition:   COVID-19 Interventions:   Biological: Low dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule;   Biological: Medium dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule;   Biological: High dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule;   Biological: Placebo on a 0- a nd 28-day schedule Sponsors:   Chinese Academy of Medical Sciences;   West China Second University Hospital;   Yunnan Center for Disease Control and Preventi...
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   SARS-CoV-2 Interventions:   Biological: mRNA-1273;   Biological: Placebo Sponsors:   ModernaTX, Inc.;   Biomedical Advanced Research and Development Authority;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Cancer of the Head and Neck Interventions:   Drug: INCAGN01876;   Drug: INCMGA00012;   Biological: DPV-001 Sponsor:   Providence Health & Services Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy & Immunology | Biology | Fish | Vaccines